Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xian Pan

Showing results (91-100 of 297) with videos related to

Pageof 30
Sort By:
Scientifica|June 28, 2024
<i>ARHGAP4</i> Inhibits Proliferation and Growth of SW620 Colon Cancer Cells by Cell Cycle and Differentiation PathwaysMing-Sheng Fu, Shu-Xian Pan, Xun-Quan Cai, et al.
Angewandte Chemie (International Ed. in English)|October 4, 2024
Phenanthridine-based Covalent Organic Frameworks for Boosting Overall Solar H<sub>2</sub>O<sub>2</sub> ProductionJie-Yu Yue, Jing-Xian Luo, Zi-Xian Pan, et al.
Trends in Endocrinology and Metabolism: TEM|March 7, 2021
From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor NetworksNikolai Jaschke, Sophie Pählig, Ying-Xian Pan, et al.
Biochemical and Biophysical Research Communications|February 19, 2003
Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1XYing-Xian Pan, Jin Xu, Loriann Mahurter, et al.
Cellular and Molecular Neurobiology|October 31, 2020
Correction to: Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1Ankita Narayan, Amanda Hunkele, Jin Xu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 30, 2005
Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimensLiang Cheng, Timothy D Jones, Chong-Xian Pan, et al.
BMC Genomics|November 24, 2012
Identification of novel genes involved in DNA damage response by screening a genome-wide Schizosaccharomyces pombe deletion libraryXian Pan, Bingkun Lei, Nan Zhou, et al.
Advanced Therapeutics|October 19, 2020
Novel nanococktail of a dual PI3K/mTOR inhibitor and cabazitaxel for castration-resistant prostate cancerYee Huang, Xiangdong Xue, Xiaocen Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2009
Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actionsYing-Xian Pan, Jin Xu, Mingming Xu, et al.
Antibodies (Basel, Switzerland)|August 27, 2024
A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph NodesFelix Stader, Cong Liu, Abdallah Derbalah, et al.
Pageof 30

Showing results (91-100 of 297) with videos related to

Sort By:
Pageof 30
Scientifica|June 28, 2024
<i>ARHGAP4</i> Inhibits Proliferation and Growth of SW620 Colon Cancer Cells by Cell Cycle and Differentiation PathwaysMing-Sheng Fu, Shu-Xian Pan, Xun-Quan Cai, et al.
Angewandte Chemie (International Ed. in English)|October 4, 2024
Phenanthridine-based Covalent Organic Frameworks for Boosting Overall Solar H<sub>2</sub>O<sub>2</sub> ProductionJie-Yu Yue, Jing-Xian Luo, Zi-Xian Pan, et al.
Trends in Endocrinology and Metabolism: TEM|March 7, 2021
From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor NetworksNikolai Jaschke, Sophie Pählig, Ying-Xian Pan, et al.
Biochemical and Biophysical Research Communications|February 19, 2003
Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1XYing-Xian Pan, Jin Xu, Loriann Mahurter, et al.
Cellular and Molecular Neurobiology|October 31, 2020
Correction to: Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1Ankita Narayan, Amanda Hunkele, Jin Xu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 30, 2005
Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimensLiang Cheng, Timothy D Jones, Chong-Xian Pan, et al.
BMC Genomics|November 24, 2012
Identification of novel genes involved in DNA damage response by screening a genome-wide Schizosaccharomyces pombe deletion libraryXian Pan, Bingkun Lei, Nan Zhou, et al.
Advanced Therapeutics|October 19, 2020
Novel nanococktail of a dual PI3K/mTOR inhibitor and cabazitaxel for castration-resistant prostate cancerYee Huang, Xiangdong Xue, Xiaocen Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2009
Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actionsYing-Xian Pan, Jin Xu, Mingming Xu, et al.
Antibodies (Basel, Switzerland)|August 27, 2024
A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph NodesFelix Stader, Cong Liu, Abdallah Derbalah, et al.
Pageof 30